$NXGL

Levy Adam R. sold $2K of NXGL

Levy Adam R. (Chief Executive Officer) sold 3,000 shares of NEXGEL, INC. (NXGL) at $0.60 on 2026-05-27.

Original reporting
SEC EDGAR · Levy Adam R.
Published May 30, 2026, 12:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 30, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXGL
Bearish
medium confidence
Mentioned
$NXGL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXGLBearishLow
01

Why it matters

The disclosure updates the insider’s holdings (354,692 shares after sale) and can influence sentiment, but it does not provide new operational/financial guidance or events.

02

Market read

Traders may factor the insider sale into near-term sentiment, but the filing alone is unlikely to be a primary catalyst.

03

What to watch

No 10b5-1 plan is cited; however, absence of a plan in the snippet does not confirm intent or timing of future selling/buying.

Relevance 6/10Novelty 3/10Timing: Filed May 29, 2026; sale dated May 27, 2026.

Background

The article is an SEC Form 4 insider transaction disclosure for NEXGEL, Inc. (NXGL).

Company-level read

Ticker impact

$NXGLBearishMedium confidence
Context

NEXGEL CEO Levy Adam R. filed an open-market sale of 3,000 shares at $0.5975 on May 27, 2026 (Form 4).

Expected impact

Likely small, short-lived downside bias; not expected to drive a sustained move without accompanying company-specific news.

Evidence & confidence

The filing discloses a single officer sale with no stated catalyst; Form 4 insider transactions are often routine and may not reflect near-term business changes.

Market effects

No broader sector signal; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale may be unrelated to fundamentals (e.g., diversification, tax planning) and is not evidence of deteriorating prospects by itself.

Key entities

  • NEXGEL, INC.

    Public company whose CEO filed an insider sale (Form 4).

  • Levy Adam R.

    Chief Executive Officer and director who sold 3,000 shares open-market.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content